Burning Rock Biotech Limited (BNR)

Burning Rock Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 26, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	384	69	98	237	996	2,398
Market Cap Growth	406.72%	-29.38%	-58.57%	-76.25%	-58.45%	-
Enterprise Value	317	13	13	103	755	2,051
Last Close Price	35.07	6.75	9.30	22.50	95.30	231.00
PS Ratio	4.93	0.98	1.29	2.90	12.46	36.42
PB Ratio	4.89	0.87	0.91	1.41	3.43	6.47
P/TBV Ratio	4.89	0.87	0.91	1.41	3.44	6.48
EV/Sales Ratio	4.19	0.18	0.18	1.27	9.44	31.15
Debt / Equity Ratio	0.06	0.09	0.02	0.04	0.05	0.02
Asset Turnover	0.60	0.54	0.41	0.29	0.21	0.25
Inventory Turnover	2.41	2.33	1.75	1.45	1.50	1.84
Quick Ratio	2.81	2.60	2.96	2.58	4.38	9.84
Current Ratio	3.15	2.92	3.36	3.06	4.89	10.45
Return on Equity (ROE)	-20.25%	-51.38%	-67.85%	-64.67%	-37.35%	-26.44%
Return on Assets (ROA)	-6.23%	-20.93%	-31.84%	-31.70%	-20.16%	-14.68%
Return on Capital Employed (ROCE)	-15.50%	-52.10%	-86.20%	-83.40%	-41.80%	-17.00%
Earnings Yield	-4.51%	-68.58%	-94.01%	-59.50%	-12.59%	-2.60%
FCF Yield	-1.44%	-19.33%	-37.95%	-32.29%	-10.88%	-0.95%
Buyback Yield / Dilution	-3.79%	-0.53%	1.46%	0.29%	-51.83%	-192.26%

Updated Nov 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q